Impact BioMedical Inc.
General ticker "IBO" information:
- Sector: Health Care
- Industry: Biotechnology
- Capitalization: $52.4M (TTM average)
Impact BioMedical Inc. does not follow the US Stock Market performance with the rate: -22.7%.
Estimated limits based on current volatility of 5.8%: low 4.02$, high 4.51$
Factors to consider:
- Total employees count: 8 (0.0%) as of 2025
- Company does not operate outside North America (retrieved using AI)
- Top business risk factors: Liquidity and credit risks, Clinical trial failure, Regulatory and compliance, Intellectual property risks, Product recalls
Short-term IBO quotes
Long-term IBO plot
Financial data
| YTD | 2022-12-31 | 2023-12-31 | 2024-12-31 |
|---|---|---|---|
| Operating Revenue | $0.05MM | $0.00MM | $0.00MM |
| Operating Expenses | $3.45MM | $4.03MM | $28.75MM |
| Operating Income | $-3.40MM | $-4.03MM | $-28.75MM |
| Non-Operating Income | $-4.47MM | $-0.38MM | $4.02MM |
| Interest Expense | $0.46MM | $0.44MM | $1.06MM |
| R&D Expense | $1.23MM | $1.69MM | $0.28MM |
| Income(Loss) | $-7.88MM | $-4.41MM | $-24.74MM |
| Taxes | $-0.62MM | $0.00MM | $0.03MM |
| Net Income(Loss)* | $-7.05MM | $-4.34MM | $-24.71MM |
| Stockholders Equity | $29.56MM | $25.22MM | $4.26MM |
| Assets | $46.50MM | $44.63MM | $20.29MM |
| Operating Cash Flow | $-2.24MM | $-2.85MM | $-3.92MM |
| Capital expenditure | $0.28MM | $0.02MM | $0.00MM |
| Investing Cash Flow | $-0.35MM | $-0.01MM | $0.00MM |
| Financing Cash Flow | $2.55MM | $2.87MM | $5.92MM |
| Earnings Per Share** | $-7.74 | $-0.91 | $-7.47 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.